雜志介紹

Lancet Oncology雜志介紹

《Lancet Oncology》是一本以English為主的未開放獲取國(guó)際優(yōu)秀期刊，中文名稱柳葉刀腫瘤學(xué)，本刊主要出版、報(bào)道醫(yī)學(xué)-ONCOLOGY領(lǐng)域的研究動(dòng)態(tài)以及在該領(lǐng)域取得的各方面的經(jīng)驗(yàn)和科研成果，介紹該領(lǐng)域有關(guān)本專業(yè)的最新進(jìn)展，探討行業(yè)發(fā)展的思路和方法，以促進(jìn)學(xué)術(shù)信息交流，提高行業(yè)發(fā)展。該刊已被國(guó)際權(quán)威數(shù)據(jù)庫(kù)SCIE收錄，為該領(lǐng)域相關(guān)學(xué)科的發(fā)展起到了良好的推動(dòng)作用，也得到了本專業(yè)人員的廣泛認(rèn)可。該刊最新影響因子為41.6，最新CiteScore 指數(shù)為62.1。

本刊近期中國(guó)學(xué)者發(fā)表的論文主要有：

• Mutational analysis of microsatellite-stable gastrointestinal cancer with high tumour mutational burden: a retrospective cohort study

  Author: Wang, Jingyuan; Xiu, Joanne; Farrell, Alex; Baca, Yasmine; Arai, Hiroyuki; Battaglin, Francesca; Kawanishi, Natsuko; Soni, Shivani; Zhang, Wu; Millstein, Joshua; Shields, Anthony F.; Grothey, Axel; Weinberg, Benjamin A.; Marshall, John L.; Lou, Emil; Khushman, Moh'd; Sohal, Davendra P. S.; Hall, Michael J.; Liu, Tianshu; Oberley, Matthew; Spetzler, David; Korn, W. Michael; Shen, Lin; Lenz, Heinz-Josef

• Artificial intelligence-based model for lymph node metastases detection on whole slide images in bladder cancer: a retrospective, multicentre, diagnostic study

  Author: Wu, Shaoxu; Hong, Guibin; Xu, Abai; Zeng, Hong; Chen, Xulin; Wang, Yun; Luo, Yun; Wu, Peng; Liu, Cundong; Jiang, Ning; Dang, Qiang; Yang, Cheng; Liu, Bohao; Shen, Runnan; Chen, Zeshi; Liao, Chengxiao; Lin, Zhen; Wang, Jin; Lin, Tianxin

• Prevalence of human papillomavirus DNA and p16INK4a positivity in vulvar cancer and vulvar intraepithelial neoplasia: a systematic review and meta-analysis

  Author: Li, Zhuang; Liu, Penglin; Wang, Ziying; Zhang, Zhaoyang; Chen, Zhongshao; Chu, Ran; Li, Guiju; Han, Qiuyue; Zhao, Yong; Li, Li; Miao, Jinwei; Kong, Beihua; Song, Kun

• Deep convolutional neural network models for the diagnosis of thyroid cancer – Authors' reply

  Author: Xiangchun Li, Sheng Zhang, Qiang Zhang, Xi Wei, Ming Gao, Wei Zhang, Kexin Chen

英文介紹

Lancet Oncology雜志英文介紹

The Lancet Oncology publishes interesting and informative reviews on any topic connected with oncology, and considers any original research contribution that advocates change in, or illuminates, oncological clinical practice. Manuscripts must be solely the work of the author(s) stated, must not have been previously published elsewhere, and must not be under consideration by another journal. All papers should be written to be clearly understandable to the journal’s readers in a wide range of specialties and countries.